- Case-Based Modules
- Initial Evaluation
- Dermatologic Manifestations
- Oral Manifestations
- OIs: Prophylaxis
- OIs: Treatment
- Antiretroviral Rx
- Antiretroviral Rx: Resistance
- Antiretroviral Rx: Adverse Effects
- Drug-Drug Interactions
- Postexposure Prophylaxis
- Perinatal Transmission
- Special Populations
- Prevention for Positives
- Challenging Unknowns
- This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
Site Map
- Initial Evaluation
- Learning Objectives
- Case 1: Acute (Primary) HIV Infection
- Case 2: HIV Classification
- Case 3: Appropriate Serologic Testing
- Case 4: Appropriate Vaccinations
- Dermatologic Manifestations
- Learning Objectives
- Case 1: Herpes Simplex Virus Infection
- Case 2: Acyclovir-Resistant Herpes Simplex Virus Infection
- Case 3: Kaposi's Sarcoma
- Case 4: Varicella Zoster Virus
- Case 5: Molluscum Contagiosum
- Oral Manifestations
- Learning Objectives
- Case 1: Oral Candidiasis
- Case 2: Oral Hairy Leukoplakia
- Case 3: Aphthous Stomatitis
- Case 4: Fluconazole-Resistant Oropharyngeal Candidiasis
- Opportunistic Infections: Prophylaxis
- Learning Objectives
- Case 1: Prophylaxis for Pneumocystis Pneumonia
- Case 2: Prophylaxis for Toxoplasma Encephalitis
- Case 3: Prophylaxis for Mycobacterium avium complex
- Case 4: Latent Tuberculosis Infection
- Opportunistic Infections: Treatment
- Learning Objectives
- Case 1: A 39-Year-Old with Headache, Fever, and Confusion
- Case 2: A 40-Year-Old with Fever and Respiratory Symptoms
- Case 3: A 36-Year-Old with Headache, Fever, and a Seizure
- Case 4: A 32-Year-Old with Fever, Weight Loss, and Fatigue
- Case 5: A 32-Year-Old with Chronic Cough
- Case 6: A 37-Year-Old Migrant Worker with Diarrhea
- Case 7: A 43-Year-Old with New Visual Symptoms
- Antiretroviral Rx
- Learning Objectives
- Case 1: Indications for Initiating Antiretroviral Therapy
- Case 2: Antiretroviral Regimens for Initial Therapy
- Case 3: Laboratory Monitoring after Initiating Antiretroviral Therapy
- Case 4: Antiretroviral Therapy for Acute (Primary) HIV
- Antiretroviral RX: Resistance
- Learning Objectives
- Case 1: I ndications for Resistance Testing
- Case 2: Features of Genotypic and Phenotypic Resistance Assays
- Case 3: Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors
- Case 4: Resistance to Nelfinavir
- Antiretroviral RX: Adverse Effects
- Learning Objectives
- Case 1: Abacavir Hypersensitivity Reaction
- Case 2: Nevirapine-Induced Hepatotoxicity
- Case 3: Indinavir Nephrotoxicity
- Case 4: Didanosine-associated Pancreatitis
- Case 5: Lactic Acidemia
- Case 6: Protease Inhibitor-Associated Hyperbilirubinemia
- Drug-Drug Interactions
- Learning Objectives
- Case 1: Drug Interactions with Antiretroviral Medications
- Case 2: Antiretrovirals and Tuberculosis Therapy
- Case 3: Antiretrovirals and Methadone
- Case 4: Antiretrovirals and Oral Contraceptives
- Case 5: Antiretrovirals and Statins
- Postexposure Prophylaxis
- Learning Objectives
- Case 1: Risk Factors for HIV Transmission in Percutaneous Exposure
- Case 2: Initial Evaluation and Postexposure Prophylaxis
- Case 3: Management of a Needlestick Injury: Source Patient of Unknown Serostatus
- Case 4: Exposure to Hepatitis C Virus
- Case 5: Nonoccupational Exposure to HIV
- Perinatal Transmission
- Learning Objectives
- Case 1: Antiretroviral Therapy During Pregnancy to Prevent Perinatal HIV Transmission
- Case 2: Presentation in Labor with No Prior Antiretroviral Therapy
- Case 3: Perinatal HIV Transmission and Route of Delivery
- Case 4: Management and Monitoring of Neonates Born to HIV-Infected Mothers
- Special Populations
- Learning Objectives
- Case 1: Methamphetamine Use and HIV
- Case 2: Heroin Use and HIV
- Case 3: HIV Infection in the Correctional Setting
- Case 4: Transgender Women and HIV
- Case 5: Homelessness and HIV
- Case 6: African Americans with HIV: Epidemiology and Risk Factors
- Prevention for Positives
- Learning Objectives
- Case 1: High-Risk Behavior Among HIV-infected Individuals
- Case 2: Screening for High-risk Behavior
- Case 3: Sexually Transmitted Diseases Screening in HIV-infected Individuals
- Case 4: STDs and HIV Transmission
- Case 5: Partner Notification and Counseling Services for HIV
Copyright © 2004-2008 University of Washington